Oslo, Norway, and London, United Kingdom (October 2021) – Calpro AS and Ampersand Health have announced a new partnership integrating the CalproSmart™ Self-Test into Ampersand’s My IBD Care, a disease-specific digital therapeutic app for people with inflammatory bowel disease.
The partnership between Ampersand and Calpro will see CalproSmart biomarker test results incorporated into Ampersand’s digital therapeutic ”My IBD Care” dashboard for greater patient oversight for NHS clinicians. The collaboration enables greater patient autonomy and self-management, as well as a more accurate view of greater disease progression for clinicians, it also helps reduce the administrative burden on healthcare professionals and provides faster, more responsive support for people living with IBD.